Ultimaster™ Tansei™ Sirolimus Eluting Coronary Stent System | 合法醫療器材資訊網

Ultimaster™Tansei™providesenhancedpushability2andexcellentkinkresistance2withastainlesssteeltaperedcorewireattheexitportandadvancedshaft ...

Based on data from e-Ultimaster clinical study, data on file Terumo Europe

PCI – Percutaneous Coronary Intervention

1 Internal report ISCD-523-37-19 - Report-eUM-Interim analysis

2 Bench test ISCD-523-31-18 performed by, and on file at Terumo Corporation

3 ULTIMASTER Clinical Program

4 Chevalier et al. Circ Cardiovasc Interv 2017;10:doi:10.1161/CIRCINTERVENTIONS.116.004801

* Patients should be maintained on clinically adequate post-procedural antiplatelet therapy according to the current guidelines. In case of need, dual antiplatelet therapy can be discontinued earlier, but not before one month.

5 Windecker S et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the Euro...